The development of inhaled generic medicines presents a number of unique challenges in terms of the product formulation, device design, drug-device combination, reference product performance and the regulatory environment.
This webinar explores the key considerations and strategies for demonstrating equivalence, accelerating development and reducing late-stage product development risks.
In this webinar you’ll learn:
• How the current regulatory environment impacts the development of inhaled generic medicines
• The application of new techniques and methodologies to increase product understanding
• How to consider equivalence in device design and performance
• The importance of process understanding to enable efficient manufacturing scale-up
Who should attend:
• Pharmaceutical and biotech companies developing inhaled medicines
• Manager/Director/Senior Director/Vice President/SVP, R&D
• Manager/Director/Senior Director/Vice-President/SVP, Product Development
• Manager/Director/Senior Director/Vice President/SVP, Procurement and Sourcing
• Manager/Director/Senior Director/Vice President/SVP, Inhaled Device Development